After years of discussions, Japan has finally started to move closer to revising strict regulations to allow the clinical development and medical use of cannabis-derived drugs.
A recent summary on the topic published by a special committee on cannabis regulation under the Ministry of Health, Labour and Welfare (MHLW) proposes the country should revise Section 4...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?